vTv Therapeutics Shares Initiated With Buy Rating, $13 Target By: Benzinga via Benzinga September 26, 2016 at 11:46 AM EDT HC Wainwright has started coverage of vTv Therapeutics Inc (NASDAQ: VTVT) with a Buy rating and $13 price target on the potential ... Read More >> Related Stocks: Astrazeneca Plc ADR Eli Lilly Gsk Plc ADR Johnson & Johnson Merck & Co Novartis Ag ADR Novo Nordisk A/S ADR Sanofi-Aventis S.A. ADR Takeda Pharma Vtv Theraptcs Cl A